Statins and Type 2 Diabetes Mellitus: An Update After 1 Year

被引:10
|
作者
Katsiki, Niki [1 ]
Athyros, Vasilios G. [1 ]
Karagiannis, Asterios [1 ]
Mikhailidis, Dimitri P. [2 ,3 ]
机构
[1] Aristotle Univ Thessaloniki, Propedeut Dept Internal Med 2, Sch Med, Hippocrat Hosp, GR-54006 Thessaloniki, Greece
[2] UCL, Dept Clin Biochem, Vasc Dis Prevent Clin, Sch Med, Royal Free Campus, London NW3 2QG, England
[3] UCL, Dept Surg, Sch Med, Royal Free Campus, London NW3 2QG, England
关键词
IMPROVE-IT; diabetes mellitus; cancer; statins; new onset diabetes; ezetimibe; COLORECTAL-CANCER; PROSTATE-CANCER; POSTPRANDIAL TRIGLYCERIDES; CARDIOVASCULAR RISK; FAT INTAKE; EZETIMIBE; THERAPY; LIPOPROTEINS; MORTALITY; ASPIRIN;
D O I
10.2174/1381612822666160125114626
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a review [1] published in this journal in 2014 we updated the role of statin treatment in patients with type 2 diabetes mellitus (T2DM). This is an important topic because the prevalence of T2DM is increasing and this disease is associated with a high risk of cardiovascular disease (CVD) as well as microvascular complications [1]. The relationship between T2DM and statins is further complicated since these drugs can cause new onset diabetes (NOD) although there is an overall benefit in terms of preventing vascular events [1, 2]. The cost implications of T2DM in terms of quality of life as well as providing healthcare are obvious. This is a brief update of our earlier review [1] based on recently published data.
引用
下载
收藏
页码:2723 / 2725
页数:3
相关论文
共 50 条
  • [1] The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update
    Katsiki, N.
    Athyros, V. G.
    Karagiannis, A.
    Mikhailidis, D. P.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (24) : 3565 - 3565
  • [2] The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update
    Katsiki, Niki
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (22) : 3665 - 3674
  • [3] Lipid management with statins in type 2 diabetes mellitus
    Irons, BK
    Kroon, LA
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (10) : 1714 - 1719
  • [4] Use of statins and the incidence of type 2 diabetes mellitus
    Bernardi, Andre
    Rocha, Viviane Zorzanelli
    Faria-Neto, Jose Rocha
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2015, 61 (04): : 375 - 380
  • [5] Statins treatment in patients with type 2 diabetes mellitus
    Kosana, S. K.
    Suzana, S. S.
    Gordana, T. G.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 159S - 160S
  • [6] Type 2 Diabetes Mellitus and Hypertension: An Update
    Lastra, Guido
    Syed, Sofia
    Kurukulasuriya, L. Romayne
    Manrique, Camila
    Sowers, James R.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (01) : 103 - +
  • [7] Update on the treatment of type 2 diabetes mellitus
    Jose Marin-Penalver, Juan
    Martin-Timon, Iciar
    Sevillano-Collantes, Cristina
    Javier del Canizo-Gomez, Francisco
    WORLD JOURNAL OF DIABETES, 2016, 7 (17) : 354 - 395
  • [8] Primary cardiovascular prevention with statins in type 2 diabetes mellitus
    Cuende, Jose I.
    MEDICINA CLINICA, 2015, 144 (09): : 431 - 432
  • [9] Pathogenesis of type 1 diabetes mellitus - Update 2010
    Achenbach, P.
    Krause, S.
    Ziegler, A. -G.
    DIABETOLOGIE UND STOFFWECHSEL, 2010, 5 (03) : R29 - +
  • [10] Update on Type 2 Diabetes Mellitus and Older Adults
    Kaminsky, Taylor
    Ozalas, Stephanie M.
    Brandt, Nicole J.
    JOURNAL OF GERONTOLOGICAL NURSING, 2020, 46 (04): : 6 - 12